Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2013 Apr 3;54(5):369–383. [Article in Spanish] doi: 10.1016/S0001-6519(03)78425-8

Documento de consenso sobre "tratamiento antimicrobiano de la faringoamigdalitis"

C Cenjor 1, JA García-Rodríguez 1, A Ramos 2, J Cervera 2, M Tomás 2, F Asensi 3, JL Cañada 5, M Gobernado 1, T Isasiá 6, C López-Madroñero 4, M Martínez 6, F Pérez-Escanilla 4, J Picazo 1, J Prieto 1, T Sampelayo 3
PMCID: PMC7111178  PMID: 12916480

The content is available as a PDF (217.4 KB).

Referencias

  • 1.CDC. Diphtheria outbreak-Russian Federation, 1990-1993. MMWR Morb Mortal Wkly Rep. 1993;42(847):840–841. [PubMed] [Google Scholar]
  • 2.Romero Vivas J., Sánchez A., Corral O., Rubio M., Picazo J.J. Estudio de las infecciones pediátricas en el medio extrahospitalario. Rev Anales Esp Pediatría. 1994;63:112–116. [Google Scholar]
  • 3.Romero Vivas J., Rubio Alonso M., Corral O., Pacheco S., Agudo E., Picazo J.J. Estudio de las infecciones respiratorias extrahospitalarias. Enferm Infecc Microbiol Clin. 1997;15:289–298. [PubMed] [Google Scholar]
  • 4.Douglas J.W., Waller R.E. Air pollution and respiratory infection in Children. Br J Prev Soc Med. 1966;20:1–11. [Google Scholar]
  • 5.Colley J.R., Douglas J.W., Reid D.D. Respiratory disease in young adults: influence of early childhood lower respiratory tract illness, social class, air pollution, and smoking. Br Med J. 1973;3:195–198. doi: 10.1136/bmj.3.5873.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Said G., Zalokar J., Lellouch J., Patois E. Parental smoking related to adenoidectomy and tonsillectomy in children. J Epidemiol Community Health. 1978;32:97–101. doi: 10.1136/jech.32.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hinton A.E., Herdman R.C., Martin-Hirsch D., Saeed S.R. Parental cigarette smoking and tonsillectomy in children. Clin Otolaryngol. 1993;18:178–180. doi: 10.1111/j.1365-2273.1993.tb00824.x. [DOI] [PubMed] [Google Scholar]
  • 8.Domenighetti G., Bisig B.E. To nsillectomy: a family-transmissible surgical procedure. Lancet. 1995;346:1376. doi: 10.1016/s0140-6736(95)92395-0. [DOI] [PubMed] [Google Scholar]
  • 9.Hedges J.R., Lowe R.A. Approach to acute pharyngitis. Emerg Med Clin North Am. 1987;5:335–351. [PubMed] [Google Scholar]
  • 10.SOCIMED GdES. Estudio Nacional de la Infección Respiratoria Madrid; 1990.
  • 11.Putto A. Febrile exudative tonsillitis: viral or streptococcal? Pediatrics. 1987;80:6–12. [PubMed] [Google Scholar]
  • 12.McMillan J.A., Sandstrom C., Weiner L.B., Forbes B.A., Woods M., Howard T., Poe L., Keller K., Corwin R.M., Winkelman J.W. Viral and bacterial organisms associated with acute pharyngitis in a school-aged population. J Pediatr. 1986;109:747–752. doi: 10.1016/s0022-3476(86)80687-4. [DOI] [PubMed] [Google Scholar]
  • 13.Ylikoski J., Karjalainen J. Acute tonsillitis in young men: etiological agents and their differentiation. Scand J Infect Dis. 1989;21:169–174. doi: 10.3109/00365548909039965. [DOI] [PubMed] [Google Scholar]
  • 14.Efstratiou A. Group A streptococci in the 1990s. J Antimicrob Chemother. 2000;45(Suppl):3–12. doi: 10.1093/jac/45.suppl_1.3. [DOI] [PubMed] [Google Scholar]
  • 15.Kaplan E.L., Gastanaduy A.S., Huwe B.B. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981;98:326–335. [PubMed] [Google Scholar]
  • 16.Komaroff A.L., Aronson M.D., Pass T.M., Ervin C.T., Branch W.T., Schachter J. Serologic evidence of chlamydial and mycoplasmal pharyngitis in adults. Science. 1983;222:927–929. doi: 10.1126/science.6415813. [DOI] [PubMed] [Google Scholar]
  • 17.Gerber M.A., Ryan R.W., Tilton R.C., Watson J.E. Role of Chlamydiatrachomatis in acute pharyngitis in young adults. J Clin Microbiol. 1984;20:993–994. doi: 10.1128/jcm.20.5.993-994.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Charnock D.R., Chapman G.D., Taylor R.E., Wozniak A. Recurrent tonsillitis. The role of Chlamydia and Mycoplasma. Arch Otolaryngol Head Neck Surg. 1992;118:507–508. doi: 10.1001/archotol.1992.01880050059014. [DOI] [PubMed] [Google Scholar]
  • 19.McCue J.D. Group G streptococcal pharyngitis. Analysis of an outbreak at a college. JAMA. 1982;248:1333–1336. doi: 10.1001/jama.248.11.1333. [DOI] [PubMed] [Google Scholar]
  • 20.Ryan W.J. Throat infection and rash associated with an unusual Corynebacterium. Lancet. 1972;2:1345–1347. doi: 10.1016/s0140-6736(72)92782-1. [DOI] [PubMed] [Google Scholar]
  • 21.Banck G., Nyman M. Tonsillitis and rash associated with Corynebacterium haemolyticum. J Infect Dis. 1986;154:1037–1040. doi: 10.1093/infdis/154.6.1037. [DOI] [PubMed] [Google Scholar]
  • 22.Huovinen P., Lahtonen R., Ziegler T., Meurman O., Hakkarainen K., Miettinen A., Arstila P., Eskola J., Saikku P. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med. 1989;110:612–616. doi: 10.7326/0003-4819-110-8-612. [DOI] [PubMed] [Google Scholar]
  • 23.Safak M.A., Haberal I., Kilic D., Gocmen H. Necrotizing fasciitis secondary to peritonsillar abscess: a new case and review of eight earlier cases. Ear Nose Throat J. 2001;80(833):824–830. [PubMed] [Google Scholar]
  • 24.Galazka A.M., Robertson S.E. Diphtheria: changing patterns in the developing world and the industrialized world. Eur J Epidemiol. 1995;11:107–117. doi: 10.1007/BF01719955. [DOI] [PubMed] [Google Scholar]
  • 25.Bachiller Luque P., Pérez Castrillon J.L., Martin Luquero M., Mena Martin F.J., de la Lama López Areal J., Pérez Pascual P., Mazon M.A., Herreros Guilarte V. Descripción preliminar de un brote epidémico de tularemia en Valladolid. Rev Clin Esp. 1998;198:789–793. [PubMed] [Google Scholar]
  • 26.Nouwen J., Smets F., Rombaux P., Hamoir M., Sokal E.M. Acute tonsillitis as the first manifestation of post-transplant lymphoproliferative disorder. Ann Otol Rhinol Laryngol. 2002;111:165–168. doi: 10.1177/000348940211100210. [DOI] [PubMed] [Google Scholar]
  • 27.Rosen G., Samuel J., Vered I. Surface tonsillar microflora versus deep tonsillar microflora in recurrent acute tonsillitis. J Laryngol Otol. 1977;91:911–913. doi: 10.1017/s0022215100084553. [DOI] [PubMed] [Google Scholar]
  • 28.Brook I., Yocum P., Shah K. Surface vs core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA. 1980;244:1696–1698. [PubMed] [Google Scholar]
  • 29.Surow J.B., Handler S.D., Telian S.A., Fleisher G.R., Baranak C.C. Bacteriology of tonsil surface and core in children. Laryngoscope. 1989;99:261–266. doi: 10.1288/00005537-198903000-00005. [DOI] [PubMed] [Google Scholar]
  • 30.Kurien M., Stanis A., Job A., Brahmadathan, Thomas K. Throat swab in the chronic tonsillitis: how reliable and valid is it? Singapore Med J. 2000;41:324–326. [PubMed] [Google Scholar]
  • 31.Colreavy M.P., Nanan D., Benamer M., Donnelly M., Blaney A.W., O’Dwyer T.P., Cafferkey M. Antibiotic prophylaxis post-tonsillectomy: is it of benefit? Int J Pediatr Otorhinolaryngol. 1999;50:15–22. doi: 10.1016/s0165-5876(99)00228-1. [DOI] [PubMed] [Google Scholar]
  • 32.Kindo A.J., Somu L., Srikanth P., Varadrajan M., Lakshmanan K. Role of surface swab, core swab and fine needle aspiration in isolating the core bacteria in inflammed tonsils. Indian J Pathol Microbiol. 2001;44:293–295. [PubMed] [Google Scholar]
  • 33.Brook I. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis. Int J Antimicrob Agents. 2001;17:439–442. doi: 10.1016/s0924-8579(01)00321-1. [DOI] [PubMed] [Google Scholar]
  • 34.Brook I. The role of beta-lactamase- producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601–607. doi: 10.1093/clinids/6.5.601. [DOI] [PubMed] [Google Scholar]
  • 35.Grahn E., Holm S.E., Roos K. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis. Scand J Infect Dis. 1987;19:421–426. doi: 10.3109/00365548709021674. [DOI] [PubMed] [Google Scholar]
  • 36.Fujimori I., Goto R., Kikushima K., Hisamatsu K., Murakami Y., Yamada T. Investigation of oral alpha-streptococcus showing inhibitory activity against pathogens in children with tonsillitis. Int J Pediatr Otorhinolaryngol. 1995;33:249–255. doi: 10.1016/0165-5876(95)01220-6. [DOI] [PubMed] [Google Scholar]
  • 37.Osterlund A., Engstrand L. An intracellular sanctuary for Strep - tococcus pyogenes in human tonsillar epithelium-studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol. 1997;117:883–888. doi: 10.3109/00016489709114219. [DOI] [PubMed] [Google Scholar]
  • 38.Bussi M., Carlevato M.T., Panizzut B., Omede P., Cortesina G. Are recurrent and chronic tonsillitis different entities? An immunological study with specific markers of inflammatory stages. Acta Otolaryngol Suppl. 1996;523:112–114. [PubMed] [Google Scholar]
  • 39.Eisen S.A., Miller D.K., Woodward R.S., Spitznagel E., Przybeck T.R. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881–1884. [PubMed] [Google Scholar]
  • 40.Roos K., Grahn E., Lind L., Holm S. Treatment of recurrent streptococcal tonsillitis by recolonization with alphastreptococci. Eur J Clin Microbiol Infect Dis. 1989;8:318–319. doi: 10.1007/BF01963463. [DOI] [PubMed] [Google Scholar]
  • 41.Dagan R., Ferne M., Sheinis M., Alkan M., Katzenelson E. An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in a closed community: mass treatment with erythromycin. J Infect Dis. 1987;156:514–516. doi: 10.1093/infdis/156.3.514. [DOI] [PubMed] [Google Scholar]
  • 42.Okada N., Tatsuno I., Hanski E., Caparon M., Sasakawa C. Strep - tococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology. 1998;144(Pt 11):3079–3086. doi: 10.1099/00221287-144-11-3079. [DOI] [PubMed] [Google Scholar]
  • 43.Neeman R., Keller N., Barzilai A., Korenman Z., Sela S. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet. 1998;352:1974–1977. doi: 10.1016/S0140-6736(97)12452-7. [DOI] [PubMed] [Google Scholar]
  • 44.Ebenfelt A. Neutrophils are hyperactive in recurrent tonsillitis. Acta Otolaryngol. 2002;122:206–209. doi: 10.1080/00016480252814243. [DOI] [PubMed] [Google Scholar]
  • 45.Garcia Callejo F.J., Orts Alborch M.H., Morant Ventura A., Costa Alcacer I., Velert Vila M.M., Blay Galaud L. Niveles de superóxido dismutasa amigdalar y eritrocitaria en niños con y sin amigdalitis de repetición. An Esp Pediatr. 2002;56:310–317. [PubMed] [Google Scholar]
  • 46.Bisno A.L. Acute pharyngitis. N Engl J Med. 2001;344:205–211. doi: 10.1056/NEJM200101183440308. [DOI] [PubMed] [Google Scholar]
  • 47.Woodwell DA. National Ambulatory Medical Care Survey. 1998 Summary. Vital and Health Statistics. Series 13, Data From the National Health Survey 2000 [PubMed]
  • 48.Bisno A.L. Streptococcus pyo-genes. In: Mandell GL, Douglas, R. G., Bennett, J. E., eds., ed. Infectious Diseases. New York. 1990:1519–1528. [Google Scholar]
  • 49.Bronze M.S., Dale J.B. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci. 1996;311:41–54. doi: 10.1097/00000441-199601000-00008. [DOI] [PubMed] [Google Scholar]
  • 50.Dajani A., Taubert K., Ferrieri P., Peter G., Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96:758–764. [PubMed] [Google Scholar]
  • 51.Givner L.B., Abramson J.S., Wasilauskas B. Apparent increase in the in cidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr. 1991;118:341–346. doi: 10.1016/s0022-3476(05)82144-4. [DOI] [PubMed] [Google Scholar]
  • 52.Pichichero M.E. Group A betahemolytic streptococcal infections. Pediatr Rev. 1998;19:291–302. doi: 10.1542/pir.19-9-291. [DOI] [PubMed] [Google Scholar]
  • 53.Stollerman G.H. Rheumatic fever in the 21st century. Clin Infect Dis. 2001;33:806–814. doi: 10.1086/322665. [DOI] [PubMed] [Google Scholar]
  • 54.Bisno A.L., Gerber M.A., Gwaltney J.M., Kaplan E.L., Schwartz R.H. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis. 1997;25:574–583. doi: 10.1086/513768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Bisno A.L., Peter G.S., Kaplan E.L. Diagnosis of strep throat in adults: are clinical criteria really good enough? Clin Infect Dis. 2002;35:126–129. doi: 10.1086/342056. [DOI] [PubMed] [Google Scholar]
  • 56.Hoffmann S. An algorithm for a selective use of throat swabs in the diagnosis of group A streptococcal pharyngo-tonsillitis in general practice. Scand J Prim Health Care. 1992;10:295–300. doi: 10.3109/02813439209014077. [DOI] [PubMed] [Google Scholar]
  • 57.Meland E., Digranes A., Skjaerven R. Assessment of clinical features predicting streptococcal pharyngitis. Scand J Infect Dis. 1993;25:177–183. doi: 10.3109/00365549309008482. [DOI] [PubMed] [Google Scholar]
  • 58.Nawaz H., Smith D.S., Mazhari R., Katz D.L. Concordance of clinical findings and clinical judgment in the diagnosis of streptococcal pharyngitis. Acad Emerg Med. 2000;7:1104–1109. doi: 10.1111/j.1553-2712.2000.tb01259.x. [DOI] [PubMed] [Google Scholar]
  • 59.Bisno A.L., Gerber M.A., Gwaltney J.M., Kaplan E.L., Schwartz R.H. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002;35:113–125. doi: 10.1086/340949. [DOI] [PubMed] [Google Scholar]
  • 60.Gwaltney JM, Bisno AL. Pharyngitis. In: Mandell GL, Douglas RG, Bennett JE, Dolin R. Eds. Mandell, Douglas and Bennett´s, ed. Principles and Practice of Infectious Diseases. 5 ed. Philadelphia 2000:656-662
  • 61.Lauer B.A., Reller L.B., Mirrett S. Effect of atmosphere and duration of incubation on primary isolation of group A streptococci from throat cultures. J Clin Microbiol. 1983;17:338–340. doi: 10.1128/jcm.17.2.338-340.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Schwartz R.H., Gerber M.A., Mc-Coy P. Effect of atmosphere of incubation on the isolation of group A streptococci from throat cultures. J Lab Clin Med. 1985;106:88–92. [PubMed] [Google Scholar]
  • 63.Komaroff A.L., Pass T.M., Aronson M.D., Ervin C.T., Cretin S., Winickoff R.N., Branch W.T. The prediction of streptococcal pharyngitis in adults. J Gen Intern Med. 1986;1:1–7. doi: 10.1007/BF02596317. [DOI] [PubMed] [Google Scholar]
  • 64.Linder J.A., Stafford R.S. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989- 1999. JAMA. 2001;286:1181–1186. doi: 10.1001/jama.286.10.1181. [DOI] [PubMed] [Google Scholar]
  • 65.Keahey L., Bulloch B., Jacobson R., Tenenbein M., Kabani A. Diagnostic accuracy of a rapid antigen test for GABHS performed by nurses in a pediatric ED. Am J Emerg Med. 2002;20:128–130. doi: 10.1053/ajem.2002.31141. [DOI] [PubMed] [Google Scholar]
  • 66.Tsevat J., Kotagal U.R. Management of sore throats in children: a cost-effectiveness analysis. Arch Pediatr Adolesc Med. 1999;153:681–688. doi: 10.1001/archpedi.153.7.681. [DOI] [PubMed] [Google Scholar]
  • 67.Catanzaro F.J., Stetson C.A., Morris L.J., Chamovitz I.R., Rammelkamp C.H.J., Stolzer B.L. Symposium on rheumatic fever and rheumatic heart disease: the role of the Streptococcus in the pathogenesis of rheumatic fever. Am J Med. 1951;17:149–156. doi: 10.1016/0002-9343(54)90219-3. [DOI] [PubMed] [Google Scholar]
  • 68.Bass J.W. Antibiotic management of group A streptococcal pharyngotonsillitis. Pediatr Infect Dis J. 1981;10:543–549. doi: 10.1097/00006454-199110001-00010. [DOI] [PubMed] [Google Scholar]
  • 69.Gerber M.A., Markowitz M. Management of streptococcal pharyngitis reconsidered. Pediatr Infect Dis. 1985;4:518–526. doi: 10.1097/00006454-198509000-00016. [DOI] [PubMed] [Google Scholar]
  • 70.Jersild T. Penicillin therapy in scarlet fever and complicating otitis. Lancet. 1948;1:671–673. doi: 10.1016/s0140-6736(48)91965-5. [DOI] [PubMed] [Google Scholar]
  • 71.Breese B.B. Treatment of beta hemolytic streptococcal infections in the home: Relative value of available methods. JAMA. 1953;521:10–14. doi: 10.1001/jama.1953.03690010016003. [DOI] [PubMed] [Google Scholar]
  • 72.Krober M.S., Bass J.W., Michels G.N. Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA. 1985;253:1271–1274. doi: 10.1001/jama.253.9.1271. [DOI] [PubMed] [Google Scholar]
  • 73.Randolph M.F., Gerber M.A., De Meo K.K., Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr. 1985;106:870–875. doi: 10.1016/s0022-3476(85)80228-6. [DOI] [PubMed] [Google Scholar]
  • 74.Nelson J.D. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis. 1984;3:10–13. doi: 10.1097/00006454-198401000-00004. [DOI] [PubMed] [Google Scholar]
  • 75.Betriu C., Sánchez A., Gómez M., Cruceyra A., Picazo J.J. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother. 1993;37:1717–1719. doi: 10.1128/aac.37.8.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Baquero F., García Rodríguez J.A., de Lomas J.G., Aguilar L. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrob Agents Chemother. 1999;43:178–180. doi: 10.1128/aac.43.1.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Gerber M.A., Randolph M.F., Chanatry J., Wright L.L., De Meo K., Kaplan E.L. Five vs ten days of penicillin V therapy for streptococcal pharyngitis. Am J Dis Child. 1987;141:224–227. doi: 10.1001/archpedi.1987.04460020114043. [DOI] [PubMed] [Google Scholar]
  • 78.Brook I., Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A betahemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Clin Pediatr (Phila) 1985;24:331–336. doi: 10.1177/000992288502400606. [DOI] [PubMed] [Google Scholar]
  • 79.Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227–233. doi: 10.1093/jac/24.2.227. [DOI] [PubMed] [Google Scholar]
  • 80.Kaplan E.L., Johnson D.R. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400–403. doi: 10.1016/s0022-3476(88)80291-9. [DOI] [PubMed] [Google Scholar]
  • 81.Rosenstein B.J., Markowitz M., Goldstein E., Kramer I., O Mansky B., Seidel H., Sigler A., Tramer A. Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. J Pediatr. 1968;73:513–520. doi: 10.1016/s0022-3476(68)80266-5. [DOI] [PubMed] [Google Scholar]
  • 82.Romero Vivas J., Betriu C., Sánchez M.L., Herranz B., Picazo J.J. Estudio de las bacterias productoras de betalactamasa en la flora faríngea en pacientes con faringitis aguda. Enferm Infecc Microbiol Clin. 1995;13:33–39. [PubMed] [Google Scholar]
  • 83.Tanz R.R., Shulman S.T., Sroka P.A., Marubio S., Brook I., Yogev R. Lack of influence of beta-lactamaseproducing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr. 1990;117:859–863. doi: 10.1016/s0022-3476(05)80122-2. [DOI] [PubMed] [Google Scholar]
  • 84.Betriu C., Campos E., Cabronero C., Fernández A., Picazo J.J., Noriega A.R. Penicillin tolerance of group A streptococci. Eur J Clin Microbiol Infect Dis. 1989;8:799–800. doi: 10.1007/BF02185849. [DOI] [PubMed] [Google Scholar]
  • 85.Kim K.S., Kaplan E.L. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr. 1985;107:681–684. doi: 10.1016/s0022-3476(85)80392-9. [DOI] [PubMed] [Google Scholar]
  • 86.Revital Neeman, Nattan Keller, Asher Barzilai, Zinaida Korenman, Shlomo Sela Prevalence of internalisation- associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. The Lancet. 1998;352:1974–1977. doi: 10.1016/S0140-6736(97)12452-7. [DOI] [PubMed] [Google Scholar]
  • 87.Schwartz R.H., Wientzen R.L., Pedreira F., Feroli E.J., Mella G.W., Guandolo V.L. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA. 1981;246:1790–1795. doi: 10.1001/jama.246.16.1790. [DOI] [PubMed] [Google Scholar]
  • 88.Bisno A.L. Primary prevention of acute rheumatic fever: Quo vadis? J Lab Clin Med. 1981;98:323–325. [PubMed] [Google Scholar]
  • 89.Shvartzman P., Tabenkin H., Rosentzwaig A., Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. BMJ. 1993;306:1170–1172. doi: 10.1136/bmj.306.6886.1170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Feder H.M., Gerber M.A., Randolph M.F., Stelmach P.S., Kaplan E.L. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999;103:47–51. doi: 10.1542/peds.103.1.47. [DOI] [PubMed] [Google Scholar]
  • 91.Pichichero M.E., Margolis P.A. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991;10:275–281. doi: 10.1097/00006454-199104000-00002. [DOI] [PubMed] [Google Scholar]
  • 92.McCarty J.M., Rentería A. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials. Clin Infect Dis. 1992;14(Suppl 2):S224–S230. doi: 10.1093/clinids/14.supplement_2.s224. discussion S231-222. [DOI] [PubMed] [Google Scholar]
  • 93.Pichichero M.E., Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J. 1997;16:680–695. doi: 10.1097/00006454-199707000-00011. [DOI] [PubMed] [Google Scholar]
  • 94.Block S.L., Hedrick J.A., Tyler R.D. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J. 1992;11:919–925. doi: 10.1097/00006454-199211110-00003. [DOI] [PubMed] [Google Scholar]
  • 95.Adam D., Hostalek U., Troster K. 5-Tagestherapie der bakteriellen Pharyngitis und Tonsillitis mit Cefixim. Vergleich zu einer 10tgigen Behandlung mit Penicillin V. Cefixim Studiengruppe. Klin Padiatr. 1996;208:310–313. doi: 10.1055/s-2008-1046489. [DOI] [PubMed] [Google Scholar]
  • 96.McCarty J.M. Comparative eff icacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. Eur J Clin Microbiol Infect Dis. 1994;13:846–850. doi: 10.1007/BF02111351. [DOI] [PubMed] [Google Scholar]
  • 97.Giovanetti E., Montanari M.P., Mingoia M., Varaldo P.E. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother. 1999;43:1935–1940. doi: 10.1128/aac.43.8.1935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Tzelepi E., Kouppari G., Mavroidi A., Zaphiropoulou A., Tzouvelekis L.S. Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece. J Antimicrob Chemother. 1999;43:745–746. doi: 10.1093/jac/43.5.745. [DOI] [PubMed] [Google Scholar]
  • 99.Kataja J., Huovinen P., Skurnik M., Seppäla H. Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother. 1999;43:48–52. doi: 10.1128/aac.43.1.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Betriu C., Casado M.C., Gómez M., Sánchez A., Palau M.L., Picazo J.J. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10- year study. Diagn Microbiol Infect Dis. 1999;33:255–260. doi: 10.1016/s0732-8893(98)00155-2. [DOI] [PubMed] [Google Scholar]
  • 101.García Bermejo I., Cacho J., Orden B., Alos J.I., Gómez Garcés J.L. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. Antimicrob Agents Chemother. 1998;42:989–990. doi: 10.1128/aac.42.4.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Pérez Trallero E., Urbieta M., Montes M., Ayestaran I., Marimon J.M. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infect Dis. 1998;17:25–31. doi: 10.1007/BF01584359. [DOI] [PubMed] [Google Scholar]
  • 103.Bellido J.L., García Saenz J.A., Manzanares M.A., Gutiérrez Zufiaurre M.N., García Rodríguez J.A. Resistencia a los macrólidos en Streptococcus pyogenes. Rev Esp Quimioter. 1998;11:196–204. [PubMed] [Google Scholar]
  • 104.Seppäla H., Klaukka T., Vuopio Varkila J., Muotiala A., Helenius H., Lager K., Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441–446. doi: 10.1056/NEJM199708143370701. [DOI] [PubMed] [Google Scholar]
  • 105.Granizo J.J., Aguilar L., Casal J., Dal Re R., Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997) J Antimicrob Chemother. 2000;46:959–964. doi: 10.1093/jac/46.6.959. [DOI] [PubMed] [Google Scholar]
  • 106.McCarty J., Hedrick J.A., Gooch W.M. Clarithromycin suspension vs penicillin V suspension in children with streptococcal pharyngitis. Adv Ther. 2000;17:14–26. doi: 10.1007/BF02868027. [DOI] [PubMed] [Google Scholar]
  • 107.Still J.G. Management of pediatric patients with group A beta-hemolytic Streptococcus pharyngitis: treatment options. Pediatr Infect Dis J. 1995;14(Suppl 3A):S57–S61. [Google Scholar]
  • 108.Betriu C., Culebras E., Redondo M., Rodriguez Avial I., Gómez M., Boloix A., Picazo J.J. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin. J Antimicrob Chemother. 2002;50:436–438. doi: 10.1093/jac/dkf128. [DOI] [PubMed] [Google Scholar]
  • 109.Giovanetti E., Montanari M.P., Marchetti F., Varaldo P.E. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Strep-tococcus pneumoniae with different erythromycin susceptibility. J Antimicrob Chemother. 2000;46:905–908. doi: 10.1093/jac/46.6.905. [DOI] [PubMed] [Google Scholar]
  • 110.Jalava J., Kataja J., Seppäla H., Huovinen P. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob Agents Chemother. 2001;45:789–793. doi: 10.1128/AAC.45.3.789-793.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Bemer-Melchior P., Juvin M.E., Tassin S., Bryskier A., Schito G.C., Drugeon H.B. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother. 2000;44:2999–3002. doi: 10.1128/aac.44.11.2999-3002.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Brook I., Gober A.E. Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatr (Phila) 1984;23:338–341. doi: 10.1177/000992288402300608. [DOI] [PubMed] [Google Scholar]
  • 113.Mehra S., van Moerkerke M., Welck J., Sverrisson G., Sirotiakova J., Marr C., Staley H. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J. 1998;17:452–457. doi: 10.1097/00006454-199806000-00003. [DOI] [PubMed] [Google Scholar]
  • 114.Pichichero M.E., Gooch W.M., Rodriguez W., Blumer J.L., Aronoff S.C., Jacobs R.F., Musser J.M. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med. 1994;148:1053–1060. doi: 10.1001/archpedi.1994.02170100051010. [DOI] [PubMed] [Google Scholar]
  • 115.Gerber M.A., Tanz R.R. New approaches to the treatment of group A streptococcal pharyngitis. Curr Opin Pediatr. 2001;13:51–55. doi: 10.1097/00008480-200102000-00009. [DOI] [PubMed] [Google Scholar]
  • 116.Kaplan E.L., Gooch III W.M., Notario G.F., Craft J.C. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin) Clin Infect Dis. 2001;32:1798–1802. doi: 10.1086/320745. [DOI] [PubMed] [Google Scholar]
  • 117.Norrby S.R., Rabie W.J., Bacarat P., Mueller O., Leroy B., Rangaraju M., Butticaz-Iroudayassamy E. Efficacy of short-course therapy with the ketolide telithromycin compared with 10 days of penicillin V for the treament of pharyngitis/tonsillitis. Scand J Infect Dis. 2002;33:883–890. doi: 10.1080/00365540110077443. [DOI] [PubMed] [Google Scholar]
  • 118.Kaplan E.L. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr. 1980;97:337–345. doi: 10.1016/s0022-3476(80)80178-8. [DOI] [PubMed] [Google Scholar]
  • 119.Gerber M.A., Randolph M.F., Mayo D.R. The group A streptococcal carrier state. A reexamination. Am J Dis Child. 1988;142:562–565. doi: 10.1001/archpedi.1988.02150050100043. [DOI] [PubMed] [Google Scholar]
  • 120.Betriu C., Romero J., Sánchez A., Sánchez M.L., Gómez M., Picazo J.J. Estudio del estado de portador de estreptococos betahemolíticos de los grupos A,B,C y G. Enferm Infecc Microbiol Clin. 1994;12:285–288. [PubMed] [Google Scholar]
  • 121.Tuner K., Nord C.E. Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1994;94:278–280. [PubMed] [Google Scholar]
  • 122.Foote P.A., Brook I. Penicillin and clindamycin therapy in recurrent tonsillitis. Effect of microbial flora. Arch Otolaryngol Head Neck Surg. 1989;115:856–859. doi: 10.1001/archotol.1989.01860310094031. [DOI] [PubMed] [Google Scholar]
  • 123.Chaudhary S., Bilinsky S.A., Hennessy J.L., Soler S.M., Wallace S.E., Schacht C.M., Bisno A.L. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr. 1985;106:481–486. doi: 10.1016/s0022-3476(85)80687-9. [DOI] [PubMed] [Google Scholar]
  • 124.Milatovic D., Knauer J. Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis. 1989;8:282–288. doi: 10.1007/BF01963451. [DOI] [PubMed] [Google Scholar]
  • 125.Llorente pendás J.L., Suárez C. Indicaciones de amigdalectomía. Bol Pediatr. 1999;39:72–75. [Google Scholar]
  • 126.Darrows D.H., Siemens C. Indications for tonsillectomy and adenoidectomy. Laringoscope. 2002;112(8pt 2):6–10. doi: 10.1002/lary.5541121404. [DOI] [PubMed] [Google Scholar]

Articles from Acta Otorrinolaringologica Espanola are provided here courtesy of Elsevier

RESOURCES